AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
Lymphocyte turnover in the setting of HIV infection
Authors: Gea-Banacloche, JC Lane, HC
Citation: Jc. Gea-banacloche et Hc. Lane, Lymphocyte turnover in the setting of HIV infection, IMMUNOLOGIS, 7(4), 1999, pp. 124-131
Effect of interleukin-2 on the pool of latently infected, resting CD4(+) Tcells in HIV-1-infected patients receiving highly active anti-retroviral therapy
Authors: Chun, TW Engel, D Mizell, SB Hallahan, CW Fischette, M Park, S Davey, RT Dybul, M Kovacs, JA Metcalf, JA Mican, JM Berrey, MM Corey, L Lane, HC Fauci, AS
Citation: Tw. Chun et al., Effect of interleukin-2 on the pool of latently infected, resting CD4(+) Tcells in HIV-1-infected patients receiving highly active anti-retroviral therapy, NAT MED, 5(6), 1999, pp. 651-655
Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection
Authors: Crandall, KA Kelsey, CR Imamichi, H Lane, HC Salzman, NP
Citation: Ka. Crandall et al., Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection, MOL BIOL EV, 16(3), 1999, pp. 372-382
Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study
Authors: Falloon, J Sargent, S Piscitelli, SC Bechtel, C LaFon, SW Sadler, B Walker, RE Kovacs, JA Polis, MA Davey, RT Lane, HC Masur, H
Citation: J. Falloon et al., Atovaquone suspension in HIV-infected volunteers: Pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study, PHARMACOTHE, 19(9), 1999, pp. 1050-1056
Immune reconstitution in HIV infection
Authors: Gea-Banacloche, JC Lane, HC
Citation: Jc. Gea-banacloche et Hc. Lane, Immune reconstitution in HIV infection, AIDS, 13, 1999, pp. S25-S38
HIV-1 replication in patients with undetectable plasma virus receiving HEART
Authors: Natarajan, V Bosche, M Metcalf, JA Ward, DJ Lane, HC Kovacs, JA
Citation: V. Natarajan et al., HIV-1 replication in patients with undetectable plasma virus receiving HEART, LANCET, 353(9147), 1999, pp. 119-120
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
Authors: Whitcup, SM Fortin, E Lindblad, AS Griffiths, P Metcalf, JA Robinson, MR Manischewitz, J Baird, B Perry, C Kidd, IM Vrabec, T Davey, RT Falloon, J Walker, RE Kovacs, JA Lane, HC Nussenblatt, RB Smith, J Masur, H Polis, MA
Citation: Sm. Whitcup et al., Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis, J AM MED A, 282(17), 1999, pp. 1633-1637
Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
Authors: Highbarger, HC Alvord, WG Jiang, MK Shah, AS Metcalf, JA Lane, HC Dewar, RL
Citation: Hc. Highbarger et al., Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples, J CLIN MICR, 37(11), 1999, pp. 3612-3614
AIDS - Re-emergence of HIV after stopping therapy
Authors: Chun, TW Davey, RT Engel, D Lane, HC Fauci, AS
Citation: Tw. Chun et al., AIDS - Re-emergence of HIV after stopping therapy, NATURE, 401(6756), 1999, pp. 874-875
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Authors: Davey, RT Bhat, N Yoder, C Chun, TW Metcalf, JA Dewar, R Natarajan, V Lempicki, RA Adelsberger, JW Millers, KD Kovacs, JA Polis, MA Walker, RE Falloon, L Masur, H Gee, D Baseler, M Dimitrov, DS Fauci, AS Lane, HC
Citation: Rt. Davey et al., HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression, P NAS US, 96(26), 1999, pp. 15109-15114
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection
Authors: Davey, RT Chaitt, DG Albert, JM Piscitelli, SC Kovacs, JA Walker, RE Falloon, J Polis, MA Metcalf, JA Masur, H Dewar, R Baseler, M Fyfe, G Giedlin, MA Lane, HC
Citation: Rt. Davey et al., A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection, J INFEC DIS, 179(4), 1999, pp. 849-858
Risultati: 1-25 | 26-36 |